Cox Christopher Nixon 4
4 · Alto Neuroscience, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Cox Christopher Nixon
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-02$3.17/sh+25,236$79,998→ 25,236 totalExercise: $4.38Exp: 2035-01-01→ Common Stock (25,236 underlying)
Footnotes (2)
- [F1]6,309 shares underlying the option shall vest on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025, subject to the Reporting Person's continuous service through each such vesting date.
- [F2]This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $80,000.